![](https://investorshub.advfn.com/uicon/170585.png?cb=1715106542)
Wednesday, September 29, 2010 6:56:04 PM
One thing I am sure of, is that the volume has been low lately (last 1-2 months was ultra low until about 2 weeks ago, and the price had already dropped 65% by the time the volume dried up), and that there is no sign of any serious new volume of new shares being sold and dumped causing the price to drop. I suspect the last few weak hands are jumping ship when some one shorts it down to new lows, OR some shorts are playing with FIRE with this one!!!!!
I looked at the chart today, and was reminded that some one shorted it down to .16 very briefly not long ago (6-8 weeks?), which may now be a support test target? The close at the low today of .18, was the days low, and was a small lot of shares at the close according to my chart, no volume, so it was just a tape labeling price exersize, IMHO, designed to scare over nighters into selling at the open. Most of the volume was at much higher prices today.
I waited nearly 12 months for the pull back to stock up on this one, and never dreamed I would see .18 buying ops! Best I hoped for was .23 at the old rally gap, gap support, but it failed.
Here is Ihubs listing of float and OS. I do not know if it is current.
http://ih.advfn.com/p.php?pid=squote&symbol=TTEG
This is from pg 23 of the last 10-Q:
During the three month period ended June 30, 2010, there was no modification of any instruments defining the rights of holders of the Company’s common stock and no limitation or qualification of the rights evidenced by the Company’s common stock as a result of the issuance of any other class of securities or the modification thereof.
During April 2010, the Company issued 40,000 shares of common stock for cash at a price of $0.34 per share.
During April 2010, the Company issued 24,000 shares of common stock for cash at a price of $0.36 per share.
During April 2010, the Company issued 1,795 shares of common stock for cash at a price of $0.39 per share.
During April 2010, the Company issued 3,570 shares of common stock for cash at a price of $0.42 per share.
During April 2010, the Company issued 2,500 shares of common stock for cash at a price of $0.43 per share.
During April 2010, the Company issued 7,955 shares of common stock for cash at a price of $0.44 per share.
During April 2010, the Company issued 10,000 shares of common stock for cash at a price of $0.45 per share.
During April 2010, the Company issued 55,000 shares of common stock for services valued at a price of $0.49 per share.
During May 2010, the Company issued 28,572 shares of common stock for cash at a price of $0.35 per share.
During May 2010, the Company issued 14,000 shares of common stock for cash at a price of $0.40 per share.
During May 2010, the Company issued 116,500 shares of common stock for cash at a price of $0.44 per share.
During June 2010, the Company issued 25,000 shares of common stock for cash at a price of $0.28 per share.
During June 2010, the Company issued 11,000 shares of common stock for services at a price of $0.30 per share.
During June 2010, the Company issued 1,000 shares of common stock for services at a price of $0.31 per share.
During June 2010, the Company issued 3,750 shares of common stock for cash at a price of $0.32 per share.
During June 2010, the Company issued 150,000 shares of common stock for services valued at a price of $0.38 per share.
During June 2010, the Company issued 100,000 shares of common stock for services valued at a price of $0.41 per share.
On June 6, 2008, the Company issued a 7 3 /4 Convertible Debenture to Golden Gate Investors, Inc. in the principal amount of $1,000,000, pursuant to Rule 506 promulgated by the Securities and Exchange Commission, for the purpose of accessing necessary funding to continue operations.
Pursuant to the terms of the Debenture, the related Securities Purchase Agreement, secured Promissory Note and Stock Pledge Agreement, each executed in connection therewith, the Company issued $1,000,000 Convertible Debenture (the “Debenture”) for the payment by Golden Gate of $100,000 in cash and the execution and delivery by Golden Gate of a $900,000 Secured Promissory Note of even date (the “Note”), bearing interest at 8% per annum.
21
Table of Contents
The Debenture bears interest at 7.75% per annum, payable monthly, maturing June 30, 2012, and is secured by a Continuing Personal Guaranty by Michael H. Rouse, the Company’s CEO. Originally, the Holder was entitled to convert into common stock of the company at the conversion price equal to the lesser of (i) $0.50, or (ii) 80% of the average of the 3 lowest Volume Weighted Average Prices during the 20 Trading Days prior to Holder’s election to convert, as such terms are defined in the Debenture. Effective January 15, 2010 the agreement was amended with the Holder and the conversion price having a $0.15 fixed floor price that limits the number of common shares upon conversion of a fixed amount. The Holder can only convert that amount of the Debenture that has actually been paid for by either cash at closing or principal pre-payments made on the Promissory Note.
Golden Gate’s secured Promissory Note is payable at the rate of 8% per annum, payable monthly and provides that for the prepayment of the Note in an amount not less than $200,000 monthly upon the happening of certain events. It matures on June 30, 2012. During 2010 and since inception, the Company has drawn $250,000 and $745,000, respectively, in proceeds related to the note. During 2010 and since inception, the Holder has converted $0 and $469,000 in convertible notes into 0 and 5,633,540 common shares, respectively.
--------------------------------------------------------
So somebody is funding the ongoing operations including a personal note guarantee by the CEO!!!!!!!!
Near as I can tell the CEO is as busy as a cat on hot tin roof right now, with the multiple deals and merger, and Falcon distributor ship all going into high gear now.
Recent NVOS News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/08/2024 09:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:30:34 PM
- Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 06/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:30:13 PM
- Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million • Business Wire • 06/06/2024 07:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 07:00:19 PM
- Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products • Business Wire • 06/05/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 07:00:34 PM
- Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note • Business Wire • 06/03/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 01:00:14 PM
- Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program • Business Wire • 05/31/2024 01:00:00 PM
- Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 05/30/2024 08:30:00 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results • Business Wire • 04/15/2024 08:30:00 PM
- Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement • Business Wire • 04/11/2024 09:00:00 PM
- Novo Integrated Sciences Provides Update on Certain Current Actions and Events • Business Wire • 03/26/2024 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:05:40 PM
- Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. • Business Wire • 02/21/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 07:00:19 PM
- Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note • Business Wire • 02/20/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 07:00:26 PM
- Novo Integrated Sciences Appoints New President • Business Wire • 02/16/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:00:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 05:00:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/22/2024 09:31:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:12 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM